Microbiota and pancreatic cancer

doi:10.3760/cma.j.issn.1673-422X.2020.01.009

Abstract

Abstract:

In recent years, driven by high-throughput sequencing technology, it has been found that changes in the proportion of specific microbiota are related to the occurrence and development of pancreatic cancer, including oral microbes, gastrointestinal flora, and pancreatic flora. Porphyromonas has a positive correlation with pancreatic cancer risk, which may provide new biomarkers for the diagnosis of pancreatic cancer. In addition, the microbiota is closely related to various treatments for pancreatic cancer. When the intestinal flora is imbalanced, it will affect the effect of chemotherapy. Bacteria in pancreatic cancer can induce immune tolerance. Complications with bacterial infection can lead to postoperative complications increase.

Key words: Microbiota, Pancreatic neoplasms, Therapy

Ji Zhouxin, He De. Microbiota and pancreatic cancer[J]. Journal of International Oncology, 2020, 47(1): 46-50.

References 39

[1]	Butel MJ, Waligora-Dupriet AJ, Wydau-Dematteis S . The developing gut microbiota and its consequences for health[J]. J Dev Orig Health Dis, 2018,9(6):590-597. DOI: 10.1017/S2040174418000119.
[2]	Oh TI, Lee JH, Kim S , et al. Fascaplysin sensitizes anti-cancer effects of drugs targeting AKT and AMPK[J]. Molecules, 2017, 23(1). pii: E42. DOI: 10.3390/molecules23010042.
[3]	Wong SH, Kwong TNY, Wu CY , et al. Clinical applications of gut microbiota in cancer biology[J]. Semin Cancer Biol, 2019,55:28-36. DOI: 10.1016/j.semcancer.2018.05.003.
[4]	Whisner CM, Athena Aktipis C . The role of the microbiome in cancer initiation and progression: how microbes and cancer cells utilize excess energy and promote one another's growth[J]. Curr Nutr Rep, 2019,8(1):42-51. DOI: 10.1007/s13668-019-0257-2.
[5]	Scanu T, Spaapen RM, Bakker JM , et al. Salmonella manipulation of host signaling pathways provokes cellular transformation associated with gallbladder carcinoma[J]. Cell Host Microbe, 2015,17(6):763-774. DOI: 10.1016/j.chom.2015.05.002.
[6]	Mascitti M, Togni L, Troiano G , et al. Beyond head and neck cancer: the relationship between oral microbiota and tumour development in distant organs[J]. Front Cell Infect Microbiol, 2019,9:232. DOI: 10.3389/fcimb.2019.00232.
[7]	Amrutkar M, Gladhaug IP . Pancreatic cancer chemoresistance to gemcitabine[J]. Cancers (Basel) , 2017, 9(11). pii: E157. DOI: 10.3390/cancers9110157.
[8]	Ertz-Archambault N, Keim P, Von Hoff D . Microbiome and pancreatic cancer: a comprehensive topic review of literature[J]. World J Gastroenterol, 2017,23(10):1899-1908. DOI: 10.3748/wjg.v23.i10.1899.
[9]	de Martel C, Ferlay J, Franceschi S , et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis[J]. Lancet Oncol, 2012,13(6):607-615. DOI: 10.1016/S1470-2045(12)70137-7.
[10]	Torres PJ, Fletcher EM, Gibbons SM , et al. Characterization of the salivary microbiome in patients with pancreatic cancer[J]. PeerJ, 2015,3:e1373. DOI: 10.7717/peerj.1373.
[11]	Wei MY, Shi S, Liang C , et al. The microbiota and microbiome in pancreatic cancer: more influential than expected[J]. Mol Cancer, 2019,18(1):97. DOI: 10.1186/s12943-019-1008-0.
[12]	Vogtmann E, Goedert JJ . Epidemiologic studies of the human microbiome and cancer[J]. Br J Cancer, 2016,114(3):237-242. DOI: 10.1038/bjc.2015.465.
[13]	Park JY, Forman D, Waskito LA , et al. Epidemiology of Helicobacter pylori and CagA-positive infections and global variations in gastric cance[J]. Toxins (Basel), 2018, 10(4). pii: E163. DOI: 10.3390/toxins10040163.
[14]	Rajagopala SV, Vashee S, Oldfield LM , et al. The human microbiome and cancer[J]. Cancer Prev Res (Phila), 2017,10(4):226-234. DOI: 10.1158/1940-6207.CAPR-16-0249.
[15]	Xiao M, Wang Y, Gao Y . Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis[J]. PLoS One, 2013,8(9):e75559. DOI: 10.1371/journal.pone.0075559.
[16]	Wang Y, Zhang FC, Wang YJ . Helicobacter pylori and pancreatic cancer risk: a meta-analysis based on 2 049 cases and 2 861 controls[J]. Asian Pac J Cancer Prev, 2014,15(11):4449-4454. DOI: 10.7314/apjcp.2014.15.11.4449-54.
[17]	Chen J, Domingue JC, Sears CL . Microbiota dysbiosis in select human cancers: evidence of association and causality[J]. Semin Immunol, 2017,32:25-34. DOI: 10.1016/j.smim.2017.08.001.
[18]	Huang J, Zagai U, Hallmans G , et al. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: a nested case-control study[J]. Int J Cancer, 2017,140(8):1727-1735. DOI: 10.1002/ijc.30590.
[19]	Gholizadeh P, Eslami H, Kafil HS . Carcinogenesis mechanisms of Fusobacterium nucleatum[J]. Biomed Pharmacother, 2017,89:918-925. DOI: 10.1016/j.biopha.2017.02.102.
[20]	Mitsuhashi K, Nosho K, Sukawa Y , et al. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis[J]. Oncotarget, 2015,6(9):7209-7220. DOI: 10.18632/oncotarget.3109.
[21]	Dickson I . Microbiome promotes pancreatic cancer[J]. Nat Rev Gastroenterol Hepatol, 2018,15(6):328. DOI: 10.1038/s41575-018-0013-x.
[22]	Serra N, Di Carlo P, Gulotta G , et al. Bactibilia in women affected with diseases of the biliary tract and pancreas. A STROBE guidelines-adherent cross-sectional study in Southern Italy[J]. J Med Microbiol, 2018,67(8):1090-1095. DOI: 10.1099/jmm.0.000787.
[23]	Olson SH, Satagopan J, Xu Y , et al. The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study[J]. Cancer Causes Control, 2017,28(9):959-969. DOI: 10.1007/s10552-017-0933-8.
[24]	Geller LT, Barzily-Rokni M, Danino T , et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine[J]. Science, 2017,357(6356):1156-1160. DOI: 10.1126/science.aah5043.
[25]	Woo BH, Kim DJ, Choi JI , et al. Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to taxol and have higher metastatic potential[J]. Oncotarget, 2017,8(29):46981-46992. DOI: 10.18632/oncotarget.16550.
[26]	Iida N, Dzutsev A, Stewart CA , et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment[J]. Science, 2013,342(6161):967-970. DOI: 10.1126/science.1240527.
[27]	Gui QF, Lu HF, Zhang CX , et al. Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model[J]. Genet Mol Res, 2015,14(2):5642-5651. DOI: 10.4238/2015.May.25.16.
[28]	Wallace BD, Wang H, Lane KT , et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme[J]. Science, 2010,330(6005):831-835. DOI: 10.1126/science.1191175.
[29]	Kaiser J, Couzin-Frankel J . Cancer immunotherapy sweeps nobel for medicine[J]. Science, 2018,362(6410):13. DOI: 10.1126/science.362.6410.13.
[30]	Sivan A, Corrales L, Hubert N , et al. Commensal bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy[J]. Science, 2015,350(6264):1084-1089. DOI: 10.1126/science.aac4255.
[31]	Vetizou M, Pitt JM, Daillere R , et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota[J]. Science, 2015,350(6264):1079-1084. DOI: 10.1126/science.aad1329.
[32]	Pushalkar S, Hundeyin M, Daley D , et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression[J]. Cancer Discov, 2018,8(4):403-416. DOI: 10.1158/2159-8290.CD-17-1134.
[33]	Cengiz TB, Jarrar A, Power C , et al. Antimicrobial stewardship reduces surgical site infection rate, as well as number and severity of pancreatic fistulae after pancreatoduodenectomy[J]. Surg Infect (Larchmt), 2019. DOI: 10.1089/sur.2019.108.
[34]	Maatman TK, Weber DJ, Qureshi B , et al. Does the microbiology of bactibilia drive postoperative complications after pancreatoduodenectomy?[J]. J Gastrointest Surg, 2019. DOI: 10.1007/s11605-019-04432-5.
[35]	Ohgi K, Sugiura T, Yamamoto Y , et al. Bacterobilia may trigger the development and severity of pancreatic fistula after pancreatoduodenectomy[J]. Surgery, 2016,160(3):725-730. DOI: 10.1016/j.surg.2016.03.032.
[36]	Sugiura T, Mizuno T, Okamura Y , et al. Impact of bacterial contamination of the abdominal cavity during pancreaticoduodenectomy on surgical-site infection[J]. Br J Surg, 2015,102(12):1561-1566. DOI: 10.1002/bjs.9899.
[37]	Belmouhand M, Krohn PS, Svendsen LB , et al. The occurrence of enterococcus faecium and faecalis is significantly associated with anastomotic leakage after pancreaticoduodenectomy[J]. Scand J Surg, 2018,107(2):107-113. DOI: 10.1177/1457496917-731188.
[38]	Yokoyama Y, Asahara T, Nomoto K , et al. Effects of synbiotics to prevent postoperative infectious complications in highly invasive abdominal surgery [J]. Ann Nutr Metab, 2017, Suppl 1: 23-20. DOI: 10.1159/000479920.
[39]	Mima K, Nakagawa S, Sawayama H , et al. The microbiome and hepatobiliary-pancreatic cancers[J]. Cancer Lett, 2017,402:9-15. DOI: 10.1016/j.canlet.2017.05.001.